Skip to content

Effect Of Dhatryadi Ghanvati IN Adolscent Female Having Heavy Menstrual Bleeding

A Randomized Open Controlled Clinical Trail To Assess The Add on Effect of Dhatryadi Ghanvati in Taruni Asrugdar W.S.R. to Puberty Menorrhagia - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076982
Enrollment
90
Registered
2024-11-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N922- Excessive menstruation at puberty

Interventions

None listed

Sponsors

Dr Sayali Uttam Bhosale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with Irregular or Prolonged cycle more than 7 days and excessive bleeding per vagina i.e. use more than 5 pads in 24 hours during Menstruation 2.Polymenorrhagia 3.Intermenstrual Bleeding ( Anruta Artava- Chakradatta) 4. Patient with Hb 7g/dl or more than 7g/dl 5.Patient with BMI between 18-28 6.Patients with Pittaj and Vataj Asrugdar Lakshanas

Exclusion criteria

Exclusion criteria: 1. K/C/O Endocranial Disorder like Hypothyroidism Hyperthyroidism PCOS 2. K/C/O Bleeding Dyscrasias 3. K/C/O Structural Abnormalities in Genital Organ 4. K/C/O Systemic Disorder

Design outcomes

Primary

MeasureTime frame
Reduce Duration and Amount of Bleeding During Menstruation and Regulate the Menstrual CycleTimepoint: To achieve the Outcome in 90 days Follow up in every month

Secondary

MeasureTime frame
Reduce Duration and Amount of Bleeding During Menstruation to Prevent Further progress of Administration of Hormones. To Achieve the Control on Excessive BleedingTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Vishala Turlapati

Yashwant Ayurvedic College P.G. Training And Research Centre

sayalibhosale86@gmail.com7710937193

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026